PHASE-3 STUDIES WITH ETOPOSIDE (VP16-213) IN LUNG-CANCER PATIENTS

被引：0
作者：
ISSELL, BF [1 ]
ROSENBAUM, PF [1 ]
DHAFIR, RA [1 ]
机构：
[1] BRISTOL MYERS CO LABS,SYRACUSE,NY 13201
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1982年 / 7卷 / 2-3期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：239 / 239
页数：1
相关论文
共 50 条
[21]   VP16-213 IN THE THERAPY OF SMALL CELL LUNG-CANCER (SCLC) - PRELIMINARY-RESULTS IN COMBINATION CHEMOTHERAPY [J].
MARTINEZ, J ;
ESCUDERO, C ;
RAMOS, SR ;
PANIZO, AG .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) :240-240
[22]   PHASE-II STUDY OF VP16-213 (ETOPOSIDE) IN REFRACTORY METASTATIC BREAST-CARCINOMA [J].
SCHELL, FC ;
YAP, HY ;
HORTOBAGYI, GN ;
ISSELL, B ;
ESPARZA, L .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) :223-225
[23]   TREATMENT OF BRAIN METASTASES OF LUNG-CANCER WITH HIGH-DOSES OF ETOPOSIDE (VP16-213) - COOPERATIVE STUDY FROM THE GROUPE FRANCAIS PNEUMO-CANCEROLOGIE [J].
KLEISBAUER, JP ;
VESCO, D ;
OREHEK, J ;
BLAIVE, B ;
CLARY, C ;
POIRIER, R ;
SARETTO, S ;
CARLES, P ;
DONGAY, G ;
GUERIN, JC ;
MARTINAT, Y .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (02) :131-&
[24]   A PHASE-II STUDY OF VP16-213 (ETOPOSIDE) IN REFRACTORY METASTATIC BREAST-CARCINOMA [J].
SCHELL, FC ;
YAP, HY ;
BLUMENSCHEIN, GR ;
ESPARZA, L ;
ISSELL, B .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) :243-243
[25]   CARBOPLATIN (CBDCA, JM8 VP16-213 IN PREVIOUSLY UNTREATED PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC) [J].
BISHOP, JF ;
STUARTHARRIS, R ;
RAGHAVAN, D ;
OLVER, I ;
BALL, D ;
MORSTYN, G ;
ARONEY, R ;
HILLCOAT, B ;
FOX, R ;
KEFFORD, R .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1986, 16 (04) :621-621
[26]   ADRIAMYCIN, CYCLOPHOSPHAMIDE, AND ETOPOSIDE (VP-16-213) IN EXTENSIVE-STAGE SMALL CELL LUNG-CANCER [J].
MATELSKI, HW ;
LOKICH, JJ ;
HUBERMAN, MS ;
ZIPOLI, TE ;
PAUL, S ;
SONNEBORN, H ;
PHILIPS, D .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (06) :729-732
[27]   PHASE-2 STUDY OF HIGH-DOSE ETOPOSIDE (VP16-213) IN HEPATOCELLULAR-CARCINOMA [J].
SHIU, W ;
MOK, SD ;
LEUNG, N ;
LI, M ;
ZACHARIA, A ;
LI, A ;
MARTIN, C .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1987, 17 (02) :113-115
[28]   A PHASE-II EVALUATION OF VP16-213 IN ADVANCED OVARIAN-CANCER [J].
HILLCOAT, B ;
BISHOP, J ;
CAMPBELL, J .
MEDICAL AND PEDIATRIC ONCOLOGY, 1983, 11 (03) :215-215
[29]   VP 16-213 (VP16) AND CYCLOPHOSPHAMIDE IN THE TREATMENT OF PRIMITIVE LUNG-CANCER IN PHASE-M-1 [J].
ESTAPE, J ;
MILLA, A ;
AGUSTI, A ;
LLORET, JS ;
PALACIN, A ;
SORIANO, E .
CANCER, 1979, 43 (01) :72-77
[30]   VP16-213 PHASE-II STUDY SMALL CELL LUNG-CARCINOMA [J].
LARRIBA, JLG ;
CARCIA, JMM ;
GALLEGO, AO ;
ALONSO, SJ .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) :239-240
12345